Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 26 04:00PM ET
8.54
Dollar change
+0.21
Percentage change
2.52
%
IndexRUT P/E- EPS (ttm)-1.32 Insider Own13.72% Shs Outstand156.65M Perf Week1.18%
Market Cap1.34B Forward P/E- EPS next Y-1.07 Insider Trans-0.24% Shs Float135.64M Perf Month-6.05%
Income-174.34M PEG- EPS next Q-0.25 Inst Own77.39% Short Float7.72% Perf Quarter-2.73%
Sales61.44M P/S21.85 EPS this Y-16.86% Inst Trans2.46% Short Ratio9.54 Perf Half Y26.33%
Book/sh2.25 P/B3.80 EPS next Y9.68% ROA-53.42% Short Interest10.47M Perf Year94.53%
Cash/sh2.72 P/C3.14 EPS next 5Y- ROE-96.89% 52W Range3.76 - 11.77 Perf YTD91.48%
Dividend Est.- P/FCF- EPS past 5Y8.38% ROI-40.98% 52W High-27.47% Beta1.21
Dividend TTM- Quick Ratio12.94 Sales past 5Y121.20% Gross Margin90.59% 52W Low127.13% ATR (14)0.48
Dividend Ex-Date- Current Ratio13.01 EPS Y/Y TTM-52.56% Oper. Margin-229.90% RSI (14)40.68 Volatility3.96% 5.47%
Employees267 Debt/Eq0.21 Sales Y/Y TTM6.45% Profit Margin-283.74% Recom1.10 Target Price18.30
Option/ShortYes / Yes LT Debt/Eq0.21 EPS Q/Q13.74% Payout- Rel Volume0.49 Prev Close8.33
Sales Surprise-9.94% EPS Surprise9.35% Sales Q/Q2.28% EarningsNov 14 BMO Avg Volume1.10M Price8.54
SMA20-6.28% SMA50-13.53% SMA2004.82% Trades Volume540,334 Change2.52%
Date Action Analyst Rating Change Price Target Change
Oct-16-24Initiated Scotiabank Sector Outperform
Jun-20-24Upgrade TD Cowen Hold → Buy $7 → $11
May-31-24Resumed Piper Sandler Overweight $15
Feb-09-24Initiated BofA Securities Buy $15
Apr-21-23Initiated Robert W. Baird Outperform $18
Aug-10-22Resumed Berenberg Buy $15
Aug-10-21Upgrade H.C. Wainwright Neutral → Buy $17
Dec-28-20Downgrade H.C. Wainwright Buy → Neutral
Dec-17-20Initiated Berenberg Buy $27
Nov-13-20Reiterated Raymond James Strong Buy $15 → $25
Dec-13-24 07:00AM
Dec-10-24 07:30AM
Dec-03-24 07:47AM
Dec-02-24 07:30AM
Nov-26-24 07:30AM
02:06AM Loading…
Nov-15-24 02:06AM
Nov-14-24 08:40AM
07:37AM
07:00AM
Nov-13-24 07:30AM
07:17AM
Nov-12-24 07:30AM
Nov-06-24 07:30AM
Oct-15-24 07:30AM
Oct-14-24 09:59AM
04:05PM Loading…
Oct-09-24 04:05PM
07:30AM
Oct-08-24 08:50AM
Sep-25-24 07:30AM
Sep-12-24 04:05PM
Sep-05-24 07:30AM
Sep-04-24 07:30AM
Aug-09-24 09:55AM
07:30AM
Aug-07-24 08:45AM
07:38AM
07:10AM
07:00AM
Jul-31-24 07:30AM
Jul-30-24 07:30AM
04:05PM Loading…
Jul-18-24 04:05PM
Jul-10-24 08:00AM
Jul-08-24 04:05PM
Jun-13-24 04:05PM
Jun-05-24 07:30AM
Jun-04-24 04:05PM
May-07-24 09:01PM
06:07PM
04:41PM
04:05PM
May-06-24 08:16PM
07:30AM
May-03-24 07:30AM
May-01-24 07:30AM
Apr-24-24 08:30AM
Apr-18-24 03:37PM
07:00AM
Apr-16-24 04:30PM
07:00AM
Apr-15-24 07:00AM
Apr-09-24 09:35AM
07:30AM
Apr-06-24 10:00AM
Apr-01-24 10:09AM
Mar-26-24 07:30AM
Mar-13-24 06:38AM
Mar-12-24 09:55AM
Mar-11-24 05:32PM
05:25PM
04:26PM
04:05PM
Mar-05-24 07:30AM
Mar-01-24 06:30PM
Feb-29-24 08:52AM
Feb-28-24 01:40PM
Feb-26-24 12:00PM
10:00AM
Feb-25-24 02:02PM
Feb-22-24 07:32AM
07:31AM
07:30AM
Feb-21-24 09:55AM
Feb-19-24 09:00AM
Feb-18-24 08:00PM
Feb-15-24 08:00AM
Feb-13-24 07:37AM
Feb-12-24 06:27AM
Jan-30-24 09:55AM
Jan-25-24 08:00AM
Jan-10-24 08:44AM
Jan-03-24 01:15PM
Dec-18-23 04:01PM
Dec-13-23 10:09PM
04:01PM
Nov-08-23 05:18PM
08:00AM
Nov-07-23 06:47PM
04:01PM
Nov-01-23 08:00AM
07:06AM
Oct-31-23 09:00AM
Oct-30-23 09:35PM
Oct-24-23 08:00AM
Oct-03-23 04:01PM
Sep-19-23 09:00PM
Sep-06-23 08:00AM
Aug-09-23 08:00AM
Aug-08-23 11:13AM
Aug-07-23 07:15PM
06:05PM
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heier Jeffrey S.Chief Scientific OfficerNov 25 '24Sale9.012,94826,561269,059Nov 27 07:52 AM
Kaiser PeterChief Development OfficerNov 25 '24Sale9.012,89726,102213,087Nov 27 07:51 AM
Nayak SanjayChief Strategy OfficerNov 25 '24Sale9.001,81416,326174,380Nov 27 07:49 AM
Dugel PravinSee RemarksNov 25 '24Sale9.0120,680186,327791,793Nov 27 07:47 AM
SANJAY NAYAKOfficerNov 25 '24Proposed Sale8.971,81416,273Nov 25 06:42 PM
PETER KAZUO KAISEROfficerNov 25 '24Proposed Sale9.012,89726,095Nov 25 06:23 PM
PRAVIN DUGELOfficerNov 25 '24Proposed Sale9.0117,783160,186Nov 25 06:19 PM
PRAVIN DUGELOfficerNov 25 '24Proposed Sale9.012,89726,095Nov 25 05:44 PM
JEFFREY S. HEIEROfficerNov 25 '24Proposed Sale9.012,94826,550Nov 25 05:10 PM
PHILIP C. STRASSBURGEROfficerOct 16 '24Proposed Sale10.2313,125134,269Oct 16 04:25 PM
Nayak SanjayChief Strategy OfficerAug 23 '24Sale9.021,83216,525176,194Aug 27 05:19 PM
Dugel PravinSee RemarksAug 23 '24Sale9.0220,880188,338812,473Aug 27 05:17 PM
RABIA OZDENOfficerAug 27 '24Proposed Sale9.0018,333164,997Aug 27 04:18 PM
PRAVIN DUGELOfficerAug 23 '24Proposed Sale9.0220,880188,271Aug 23 05:10 PM
SANJAY NAYAKOfficerAug 23 '24Proposed Sale9.021,83216,526Aug 23 04:36 PM
RABIA OZDENOfficerAug 21 '24Proposed Sale8.9010,00089,047Aug 21 05:32 PM
RABIA OZDENOfficerAug 07 '24Proposed Sale8.5015,000127,500Aug 07 04:15 PM
ANTONY MATTESSICHFormer OfficerAug 01 '24Proposed Sale8.1923,979196,498Aug 01 04:30 PM
LINDSTROM RICHARD L MDDirectorFeb 27 '24Option Exercise8.8030,302266,658150,704Jul 26 07:30 PM
Nayak SanjayChief Strategy OfficerMay 23 '24Sale5.842,27413,280178,026May 28 05:01 PM
Dugel PravinSee RemarksMay 23 '24Sale5.7921,626125,215833,353May 28 05:00 PM
SUMMER ROAD LLC10% OwnerFeb 26 '24Buy7.52930,8517,000,0008,591,401Feb 27 04:43 PM
Notman DonaldChief Financial OfficerJan 31 '24Sale4.956,43331,843139,932Feb 02 07:03 PM
Ozden Rabia GursesChief Medical OfficerJan 31 '24Sale4.957,76438,43292,767Feb 02 07:02 PM
Strassburger Philip C.General CounselJan 31 '24Sale4.956,83133,813109,218Feb 02 07:01 PM
White Christopher GChief Business OfficerJan 31 '24Sale4.955,14725,47889,619Feb 02 07:01 PM
Mattessich Antony C.President and CEOJan 31 '24Sale4.9518,33890,773427,943Feb 02 07:00 PM